A recent study published in Nature reveals that COVID-19 mRNA vaccines, such as those from Pfizer and Moderna, can enhance the immune system's ability to fight cancer, particularly in patients undergoing immunotherapy for late-stage melanoma and lung cancer. Patients who received the vaccines alongside immunotherapy demonstrated significantly improved survival rates, suggesting a potential dual benefit of these vaccines beyond their original purpose.